Clearbridge Health Ltd. · SGX:1H3
Clearbridge Health — Q1 2019 Earnings Presentation
45 slides from Clearbridge Health's earnings presentation, May 2019
Slide 1: Redefining Healthcare in Asia with Precision
REDEFINING HEALTHCARE IN ASIA WITH PRECISION EMPOWERING PATIENT CARE WITH CLARITY Corporate Presentation Q1 2019
Slide 2: Important notice
Important Clearbridge Health Limited is a company listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). notice This presentation has been prepared by the Company and has been reviewed by the Company’s sponsor, United Overseas Bank Limited (the “Sponsor”),
Slide 3: Building the First Precision Medicine Platform in Asia with 3 Pillars
What is Precision Medicine? Why the Focus on Precision Medicine? Building the Precision An approach for disease treatment and prevention that According to a new market intelligence report by BIS Research, titled "Global Precision Medicine Market- First Precision Medicine takes into account individua
Slide 4: Our Value Creation Process
• Capitalising valuation multiple differential between public and private market Our Value Unlocking • Healthcare EV/EBITDA: 8.7x – 52.7x Creation Value • P/ EBITDA of key potential targets range from 3 – 12x Process • Maximising revenue growth by achieving economies of scope (new precision medicine
Slide 5: Enabling Better Healthcare and Treatment
Enabling Better With individual genomic profile Genomic & metabolomic driven tests Healthcare and • • Implement 5, 10 year health monitoring programs Dietary management • Health screening Treatment • GPs and dental • Aesthetics Lifestyle & Primary • Dialysis Via an ecosystem of Wellness Healthcare •
Slide 6: One of the First in Asia
One of the First Philippines - Clearbridge Medical Philippines, a Hong Kong - Medical clinic in Causeway Bay in Asia medical center in Manila - Distribution network of diagnostic - Distribution network of services diagnostic services With a diversified - ClearSkin, a derma clinic chain regional foot
Slide 7: Significant Opportunities for 3rd Party Collaborations
Significant Screening & Diagnosis Opportunities for 3rd Party Collaborations Tapping on a network of technology With our diversified Treatment Selection and clinical partners to: product and services portfolio in Asia • Enhance product and service offerings • Gain access to cutting edge R&D Monitori
Slide 8: Exponential Growth of Revenue
Quarterly revenue by segment (S$’000) Exponential 2,500 2,214 Healthcare systems 4x revenue Growth 2,000 growth • Healthcare systems comprised laboratory and renal care services providers Revenue of 1,500 1,310 • Revenue increased from S$0.14m in Q1-18 to S$1.31m in Q1- Over 4x 1,000 377 19 due to a
Slide 9: Key P&L Highlights
Key P&L Revenue S$’000 Q1 FY2019 Q1 FY2018 Q2 FY2018 Q3 FY2018 Q4 FY2018 FY2018 Highlights Revenue 2,214 377 1,456 2,052 2,250 6,135 Higher expenses in Key Expenses line with strong S$’000 revenue growth Employee 1,733 1,159 1,619 1,486 3,151 7,415 benefits expense Recurring other operating 330 991
Slide 10: Key P&L Highlights
Key P&L S$’000 Q1 Q1 Q2 Q3 Q4 FY2018 FY2019 FY2018 FY2018 FY2018 FY2018 Highlights Loss before taxation (66) (1,674) (12,159) (2,417) (2,477) (18,727) Adjusted EBITDAR Profit / (loss) attributable to 1 (1,489) (12,230) (2,505) (2,224) (18,448) owners of the Company Adjusted for following items: Fair
Slide 11: Key Balance Sheet Highlights
Key Balance S$’000 As at As at 31 Mar 2019 31 Dec 2018 Sheet Cash and bank balances 14,597 8,005 Highlights Total assets 73,839 62,762 Asset light with low debt Borrowings (current) 2,024 470 Borrowings (non-current) 11,908 2,419 Total liabilities 26,163 15,232 Net debt / Total equity 29.22% 6.08% 1
Slide 12: Key Milestones
Apr 18 Key Partnership with May 19 A Star’s GIS Acquisition of 13 clinical Milestones Partnered with Genome laboratories in Indonesia Institute of Singapore (GIS) Co-operate 13 clinical to offer Prosigna breast laboratories (pending novation cancer test Jul 18 of 3 contracts) in Indonesia Dec 17 Par
Slide 13: Acquisitions & Investments Roundup
Acquisition Year Benefits Acquisitions & CBBP 2010 • Algorithm-powered imaging technology Investments • Enables more efficient location and classification of rare cells and particles Roundup Biolidics 2011 • • Formerly known as CBB, spun off in an IPO in December 2018 World’s first fully automated c
Slide 14: Acquires Majority Stake in a Group of 9 Dental Clinics in Singapore
Acquires Majority Stake Target and transaction overview in a Group of 9 • Acquisition of 51% stake of group of 9 dental clinics, operating under the brand “Dental Focus”, in Singapore Dental Clinics • First right of refusal (“ROFR”) to acquire another 6 dental clinics and ancillary dental services p
Slide 15: Our Near-Term Focus
Our Near- 1 Healthcare services and 2 Healthcare systems 3 Strategic equity investments in medical centers medical technology companies Term Focus • Build a compelling aesthetics • Become a leading regional • Biolidics – (i) achieve lab developed business catering to all laboratory testing services
Slide 16: Our Investment Merits
Our 1 Direct proxy to the defensive and high-growth healthcare industry in Asia Investment Merits 2 Global trend of precision medicine underpins the industry’s strong prospects and market potential in Asia A fast-growing 3 Differentiated business strategy by building the first precision medicine pla
Slide 17: Q&A
Q&A 17
Slide 18: Thank you
Thank you 18
Slide 19: Appendix
Appendix 19
Slide 20: Experienced Management Team
Experienced Management Team With proven track Jeremy Yee • Former CEO - Cordlife Group Limited (SGX-listed) records in Asia’s Executive Director • Former CFO - Cordlife Limited and CEO • M.Comm (University of Sydney), MBA (Chicago Booth), healthcare industry M.A (Columbia University) Simon Hoo Dr. L
Slide 21: Dedicated and Experienced Market Development Team Across Asia
Dedicated and Indonesia Philippines Malaysia Experienced Adrian Chu Dr. Rainer Mozo Dr. Ng Ee Vern Market Sr. Regional Medical Director Medical Director Business Development Dev. Director (Philippines) (Malaysia) Team Across • Former COO of Acepio Pte Ltd – ERP solutions • Fellow, Philippine College
Slide 22: Regional Updates
Regional Updates 22
Slide 23: Singapore
Singapore 23
Slide 24: Sam Laboratory
Sam Laboratory • Moved into our new premise in March 2018. • Acquired Cobas® 6000 analyzer following the introduction of a new hormone test. 24
Slide 25: Philippines
Philippines 25
Slide 26: Clearbridge Medical Group Philippines
Clearbridge • Renovation completed February 2019. Medical Group Philippines • Improved facilities to offer comprehensive range of (CMP) diagnostic and medical services. Rebranding of Marzan Health Care • Pending the approval for the accreditation by the Department of Health as an approved Overseas F
Slide 27: Clearbridge Medical Group Philippines
Clearbridge • Dedicated Corporate Wellness Clinic for Pre- Medical Group Employment and Annual Philippines Physical Exam of private and government Multi-specialty accounts. Clinics (MSC) & Corporate Wellness • Multi-specialty clinics Clinic (CWC) offers one convenient location for major types of pri
Slide 28: Clearbridge Medical Group Philippines Dialysis Center
Clearbridge Medical Group Philippines Dialysis Center 28
Slide 29: Clearbridge Medical Group Philippines Mobile Clinic
Clearbridge • Newly revamped mobile clinic Medical Group equipped with Philippines Digital X-ray to cater to on-site Mobile Clinic annual check-ups for corporate accounts. 29
Slide 30: Clearbridge Medical Group Philippines
Clearbridge Medical Group Philippines ClearSMILE Advanced Dental Care and Diagnostics Cone Beam CT Scan Pediatric & Adult/Ortho Dentistry 3 branches ClearSkin Advanced • Quezon City, Metropolitian Manila Dermatology & • Valenzuela City & Laser Center, (located in a mixed – Philippines development bu
Slide 31: Clearbridge Medical Group Philippines Pharmacy
Clearbridge • In partnership with the Department Social Medical Group Welfare and Development (DSWD), CMP pharmacies are serving over 2,000 State- Philippines sponsored Filipinos from different government Pharmacy hospitals and agencies. Manila Branch & • Serving 21 government hospitals through Quez
Slide 32: Hong Kong
Hong Kong 32
Slide 33: Clearbridge Medical, Hong Kong
Clearbridge • Rapid growth in 2018 with Medical, monthly patient volume > 350. • Significant revenue growth Hong Kong YoY. Medical Clinic • Further diversified product and service portfolio. • Expanded collaboration with new local and Chinese business partners. • New clinic expansion plan in Clinic
Slide 34: 11th China International Medical Tourism (Shanghai) Fair
11th China International Medical Tourism (Shanghai) Fair Showcase and introduce CBH to the public and agents 34
Slide 35: Malaysia
Malaysia 35
Slide 36: Clearbridge Medica, Malaysia
Clearbridge Medica, Malaysia • MOH licensed and opened March 2019 Plaza Arkadia, • Located in a new township comprising Desa Parkcity mainly of affluent middle class new families 36
Slide 37: Clearbridge Medica, Malaysia Partnerships
Clearbridge 12 GP clinics in Klang Valley, KL Medica, Malaysia Partnerships 6 branches in Klang Valley have been shortlisted to be the outlet to provide • Hereditary Cancer Gene Test • RightMed 37
Slide 38: Indonesia
Indonesia 38
Slide 39: IGM – Indonesia
IGM – Indonesia Where we are - 13 clinical laboratories - Pending 3 contracts for novation 39
Slide 40: IGM – Indonesia
IGM – Indonesia - 13 clinical laboratories to date - Revenue sharing of 55 – 70% 40
Slide 41: IGM – Indonesia
IGM – Indonesia - Currently operating 10 JO since May Rumah Sakit Cipto Mangunkusumo Rumah Sakit Umum Pusat Sanglah Denpasar Bali Rumah Sakit Umum Daerah Dr. Zainoel Abidin 2019 - Pending 3 contracts for novation Rumah Sakit Jogja Internasional Hospital Jogja Rumah Sakit Umum Daerah Kabupaten Badung
Slide 42: PT Tirta Medika Jaya (TMJ) – Indonesia
PT Tirta Medika Jaya (TMJ) – Indonesia Where we are - 37 Hospitals 42
Slide 43: PT Tirta Medika Jaya (TMJ) – Future Targets
PT Tirta Medika Jaya (TMJ) – Indonesia Future Targets 43
Slide 44: PT Tirta Medika Jaya (TMJ) – Indonesia
PT Tirta 23 hospitals in Medika Jaya operation to date RSUD Kumpulan Pane (TMJ) – RSUD Dustira Indonesia RSUD Bayu Asih RSUD Ciamis - 23 hemodialysis RSUD Djasamen Saragih treatment RS Sari Mutiara facilities in RS Pring Sewu operation RSUD Dr Soehadi Projonegoro -Sragen RSUD Dr H Marsidi Judono - B
Slide 45: Thank you
Thank you 45